Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$26.19M+18.8%-$32.24M+14.3%-$37.62M+20.2%
$5.67M+3.2%$5.49M+3.2%$5.32M+2.5%$5.19M
$14.32M+10.5%$12.96M+12.4%$11.52M+13.6%$10.15M
$176K-38.2%$285K-25.6%$383K-14.5%$448K
-$9K-12.5%-$8K
$2.78M+35.9%$2.04M+29.7%$1.58M-10.5%
$21.72M+47.1%$14.76M+12.7%$13.1M+48.8%
$789K-33.7%$1.19M
$3.88M-38.3%$6.29M
$9.81M-7.0%$10.55M-7.8%$11.44M+216%$3.62M
-$136K+45.8%-$251K+3.1%-$259K+18.3%-$317K
-$44K$0-100%$45K-74.9%$179K
$4.51M+28.5%$3.51M-9.3%$3.87M-7.5%$4.18M
$8.79M+5.7%$8.32M+23.4%$6.74M+45.1%
$258K-42.3%$447K-29.5%$634K-15.7%$752K
-$817K
$3.56M+6.7%$3.34M+4.1%$3.21M+7.1%$3M
$1.09M-17.9%$1.32M+1.1%$1.31M+54.5%$846K
-$6.14M-5.3%-$5.83M-6.9%-$5.46M-20.3%-$4.54M
$11.7M+24.9%$9.37M+28.7%$7.28M+24.2%$5.86M
$0$0$0$0
$138.98M
$1.54M-36.3%$2.42M-27.8%$3.35M-10.3%$3.74M
$3.56M+6.7%$3.34M+4.1%$3.21M+7.1%$3M
$176K-38.2%$285K-25.6%$383K-14.5%$448K
$4.51M+28.5%$3.51M-9.3%$3.87M-7.5%$4.18M
-$817K
-$44K$0-100%$45K-74.9%$179K
$2.77M+24.2%$2.23M
$258K-42.3%$447K-29.5%$634K-15.7%$752K
$2.78M+35.9%$2.04M+29.7%$1.58M-10.5%
$5.06M+12.1%$4.51M+8.7%$4.15M+12.4%$3.69M
$3.74M-12.8%$4.28M-21.5%$5.46M+30.3%$4.19M
$948K-35.4%$1.47M
$8.79M+5.7%$8.32M+23.4%$6.74M+45.1%
-$817K
$0$0$0$0
$224K+21.7%$184K+21.1%$152K+13.4%$134K
-$494K$0

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Omada Health, Inc. Common Stock generate?
Omada Health, Inc. Common Stock (OMDA) generated -$13.1M in operating cash flow over the trailing twelve months.
What is Omada Health, Inc. Common Stock's free cash flow?
After $1.1M of capital expenditures, Omada Health, Inc. Common Stock's free cash flow was -$13.8M over the trailing twelve months, up 72.4% year over year.
Where does Omada Health, Inc. Common Stock's cash flow data come from?
Every line is extracted from Omada Health, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.